Pfeifer Philippe, Sebastian Alexandra, Buchholz Hans Georg, Kaller Christoph P, Gründer Gerhard, Fehr Christoph, Schreckenberger Mathias, Tüscher Oliver
University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
Department of Psychiatry and Psychotherapy, University Medical Center of the Johannes Gutenberg University Mainz, Untere Zahlbacher Straße 8, 55131, Mainz, Germany.
Brain Imaging Behav. 2022 Feb;16(1):186-198. doi: 10.1007/s11682-021-00491-y. Epub 2021 Aug 17.
D-like dopamine receptors in animals and humans have been shown to be linked to impulsive behaviors that are highly relevant for several psychiatric disorders. Here, we investigate the relationship between the fronto-striatal D/D dopamine receptor availability and response inhibition in a selected population of healthy OPRM1 G-allele carriers. Twenty-two participants successively underwent blood-oxygen level dependent functional magnetic resonance imaging (fMRI) while performing a stop-signal task and a separate positron emission tomography (PET) scan. Striatal and extrastriatal D/D dopamine receptor availability was measured using the radiotracer [F]fallypride. Caudate D/D dopamine receptor availability positively correlated with stopping-related fronto-striatal fMRI activation. In addition, right prefrontal D/D dopamine receptor availability correlated positively with stopping-related striatal fMRI BOLD signal. Our study partially replicates previous findings on correlations between striatal D/D dopamine receptor availability and response inhibition in a population selected for its genetic determination of dopamine response to alcohol and as a modulator of impulse control via the endogenous opioid system. We confirm the important role of D/D dopamine receptor availability in the fronto-striatal neural circuit for response inhibition. Moreover, we extend previous findings suggesting that dopamine receptor availability in the right inferior frontal cortex, a crucial region of the stopping network, is also strongly associated with stopping-related striatal fMRI activity in healthy OPRM1 G-allele carriers.
在动物和人类中,D 样多巴胺受体已被证明与冲动行为有关,而冲动行为与多种精神疾病高度相关。在此,我们在选定的健康 OPRM1 G 等位基因携带者群体中,研究额纹状体 D2/D3 多巴胺受体可用性与反应抑制之间的关系。22 名参与者在执行停止信号任务和单独的正电子发射断层扫描(PET)时,先后接受了血氧水平依赖性功能磁共振成像(fMRI)。使用放射性示踪剂[11C]fallypride 测量纹状体和纹状体外 D2/D3 多巴胺受体可用性。尾状核 D2/D3 多巴胺受体可用性与停止相关的额纹状体 fMRI 激活呈正相关。此外,右侧前额叶 D2/D3 多巴胺受体可用性与停止相关的纹状体 fMRI BOLD 信号呈正相关。我们的研究部分重复了先前关于纹状体 D2/D3 多巴胺受体可用性与反应抑制之间相关性的研究结果,该研究群体因其对酒精的多巴胺反应的遗传决定以及作为内源性阿片系统对冲动控制的调节因素而被选定。我们证实了 D2/D3 多巴胺受体可用性在额纹状体神经回路中对反应抑制的重要作用。此外,我们扩展了先前的研究结果,表明右下额叶皮质(停止网络的关键区域)中的多巴胺受体可用性也与健康 OPRM1 G 等位基因携带者中与停止相关的纹状体 fMRI 活动密切相关。